HENDERSON MICHAEL THOMAS

CIK 00017799904 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001779990

Recent Transactions

50 trades

Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-11$63.73/sh−7,551→ 1,173,942 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-11$62.96/sh−11,494→ 1,181,493 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-11$64.99/sh−955→ 1,172,987 total
Other
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-01-21+63,227→ 168,606 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-14$81.00/sh−2,374→ 1,200,697 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-14$79.82/sh−8,476→ 1,203,071 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-14$82.41/sh−1,854→ 1,198,843 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-14$83.16/sh−5,386→ 1,193,457 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-14$83.79/sh−470→ 1,192,987 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-14$78.64/sh−1,440→ 1,211,547 total
Award
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-01-02+253,016→ 253,016 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-12-10$75.79/sh−10,005→ 1,213,547 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-12-10$76.58/sh−560→ 1,212,987 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-12-10$74.88/sh−9,435→ 1,223,552 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-12-04$75.01/sh−40,000→ 1,232,987 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-13$61.93/sh−3,340→ 1,289,647 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-13$63.14/sh−14,774→ 1,274,873 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-13$64.52/sh−100→ 1,272,987 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-13$63.89/sh−1,786→ 1,273,087 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2025-05-29+25,000→ 25,000 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-03-05$29.98/sh−7,326→ 1,295,661 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-03-05$30.62/sh−2,674→ 1,292,987 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-02-05$40.58/sh−15,000→ 1,302,987 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2025-01-31−8,500→ 390,012 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-01-31$22.86/sh+8,500→ 1,317,987 total
Other
Spyre Therapeutics, Inc.$SYRE
Common Stock
2025-01-10+105,379→ 105,379 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-01-08$48.72/sh−12,132→ 1,312,355 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-01-08$49.38/sh−2,868→ 1,309,487 total
Award
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2024-12-09+357,036→ 357,036 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-12-04$47.19/sh−1,672→ 1,324,487 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-12-04$46.50/sh−13,328→ 1,326,159 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-11-06$59.94/sh−1,000→ 1,339,487 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-11-06$59.17/sh−14,000→ 1,340,487 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-10-02$56.74/sh−9,712→ 1,354,487 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-10-02$56.07/sh−30,288→ 1,364,199 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-09-04$48.23/sh−14,359→ 1,394,487 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-09-04$47.28/sh−25,641→ 1,408,846 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-08-07$41.52/sh−7,667→ 1,434,587 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-08-07$40.40/sh−32,233→ 1,442,254 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-08-07$42.17/sh−100→ 1,434,487 total
Disposition to Issuer
ARYA Sciences Acquisition Corp IV
Class B ordinary shares
2024-07-31−30,000→ 0 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2024-07-05$37.26/sh−15,000→ 1,474,487 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2024-05-14+11,323→ 11,323 total
Award
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2023-12-18+398,512→ 398,512 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-12-15+4,456→ 4,456 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-12-15+3,137→ 3,137 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-12-15+2,199→ 2,199 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-12-01$51.69/sh−6,972→ 274,211 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-12-01$51.12/sh−3,028→ 281,183 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-12-01$1.05/sh+10,000→ 284,211 total

Companies

Recent Filings

Address

C/O APOGEE THERAPEUTICS, INC. 221 CRESCENT ST., BLDG. 17, STE. 102B

WALTHAM, MA, 02453

View on SEC.gov